F. X. Weilbach
Impact in
- Pathology and Forensic Medicine top 10%
- Multiple Sclerosis Research Studies
-
- Virtual Reality Applications and Impacts
Papers in
-
- Multiple Sclerosis Research Studies 7
-
- Medical Practices and Rehabilitation 3
- Balance, Gait, and Falls Prevention 2
- Co-authors
- Andrew Chan (3 shared papers)Ralf Gold (6 shared papers)Klaus V. Toyka (1 shared paper)Klaus V. Toyka (2 shared papers)K. V. Toyka (2 shared papers)R. Gold (1 shared paper)Sonja C. Kleih (1 shared paper)Thomas Günthner‐Lengsfeld (1 shared paper)
- Journals
- Clinical & Experimental Immunology (2 papers)Journal of NeuroEngineering and Rehabilitation (1 paper)Journal of Neuroimmunology (1 paper)Journal of Cardiovascular Pharmacology (1 paper)CNS Drugs (1 paper)
- Partner nations
- GermanySlovakiaSwitzerland
In The Last Decade
F. X. Weilbach
19 papers receiving 303 citations
Peers
Comparison fields: 5 of 64
- Pathology and Forensic Medicine 101
- Human-Computer Interaction 24
- Neurology 58
- Neurology 27
- Rehabilitation 19
Countries citing papers authored by F. X. Weilbach
This map shows the geographic impact of F. X. Weilbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. X. Weilbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. X. Weilbach more than expected).
Fields of papers citing papers by F. X. Weilbach
This network shows the impact of papers produced by F. X. Weilbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. X. Weilbach. The network helps show where F. X. Weilbach may publish in the future.
Co-authors
The 25 scholars most cited alongside F. X. Weilbach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 72 | |
| 2 | 2004 | 61 | |
| 3 | 2003 | 33 | |
| 4 | 2016 | 33 | |
| 5 | 2002 | 17 | |
| 6 | 2019 | 16 | |
| 7 | 2006 | 14 | |
| 8 | 2018 | 11 | |
| 9 | 2002 | 11 | |
| 10 | Melanoma-inhibiting activity inhibits cell proliferation by prolongation of the S-phase and arrest of cells in the G2 compartment. | 1990 | 10 |
| 11 | 2020 | 8 | |
| 12 | 2003 | 8 | |
| 13 | 1999 | 7 | |
| 14 | 1997 | 6 | |
| 15 | 1997 | 3 | |
| 16 | 2016 | 2 | |
| 17 | 1999 | 1 | |
| 18 | 2002 | 1 | |
| 19 | 1996 | 1 | |
| 20 | [Cladribine in chronic progressive multiple sclerosis]. | 1995 | 0 |
About F. X. Weilbach
F. X. Weilbach is a scholar working on Pathology and Forensic Medicine, Physical Therapy, Sports Therapy and Rehabilitation, Immunology, Cardiology and Cardiovascular Medicine and Rehabilitation, having authored 20 papers that have together received 315 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (7 papers), Medical Practices and Rehabilitation (3 papers), Stroke Rehabilitation and Recovery (3 papers), Virtual Reality Applications and Impacts (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Immunotherapy and Immune Responses (2 papers), Balance, Gait, and Falls Prevention (2 papers) and Polyomavirus and related diseases (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (101 citations), Human-Computer Interaction (24 citations), Neurology (58 citations), Neurology (27 citations) and Rehabilitation (19 citations). F. X. Weilbach has collaborated with scholars based in Germany, Slovakia and Switzerland. Frequent co-authors include Andrew Chan, Ralf Gold, Klaus V. Toyka, Klaus V. Toyka, K. V. Toyka, R. Gold, Sonja C. Kleih, Thomas Günthner‐Lengsfeld, Roland Goldbrunner and Andreas J. Bartsch. Their work appears in journals such as Clinical & Experimental Immunology, Journal of NeuroEngineering and Rehabilitation, Journal of Neuroimmunology, Journal of Cardiovascular Pharmacology and CNS Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.